171 related articles for article (PubMed ID: 22028905)
1. Fluorescent peptide biosensor for probing the relative abundance of cyclin-dependent kinases in living cells.
Kurzawa L; Pellerano M; Coppolani JB; Morris MC
PLoS One; 2011; 6(10):e26555. PubMed ID: 22028905
[TBL] [Abstract][Full Text] [Related]
2. Fluorescent protein biosensor for probing CDK/cyclin activity in vitro and in living cells.
Van TN; Pellerano M; Lykaso S; Morris MC
Chembiochem; 2014 Oct; 15(15):2298-305. PubMed ID: 25209885
[TBL] [Abstract][Full Text] [Related]
3. Fluorescent biosensors for drug discovery new tools for old targets--screening for inhibitors of cyclin-dependent kinases.
Prével C; Kurzawa L; Van TN; Morris MC
Eur J Med Chem; 2014 Dec; 88():74-88. PubMed ID: 25314935
[TBL] [Abstract][Full Text] [Related]
4. Fluorescent Peptide Biosensors for Probing CDK Kinase Activity in Cell Extracts.
Pellerano M; Morris MC
Methods Mol Biol; 2021; 2329():39-50. PubMed ID: 34085214
[TBL] [Abstract][Full Text] [Related]
5. Fluorescent biosensors - probing protein kinase function in cancer and drug discovery.
Morris MC
Biochim Biophys Acta; 2013 Jul; 1834(7):1387-95. PubMed ID: 23376184
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the interactions between human cdc25C, cdks, cyclins and cdk-cyclin complexes.
Morris MC; Divita G
J Mol Biol; 1999 Feb; 286(2):475-87. PubMed ID: 9973565
[TBL] [Abstract][Full Text] [Related]
7. Fluorescent peptide biosensor for monitoring CDK4/cyclin D kinase activity in melanoma cell extracts, mouse xenografts and skin biopsies.
Prével C; Pellerano M; González-Vera JA; Henri P; Meunier L; Vollaire J; Josserand V; Morris MC
Biosens Bioelectron; 2016 Nov; 85():371-380. PubMed ID: 27203461
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of cyclin-dependent kinase regulation: structures of Cdks, their cyclin activators, and Cip and INK4 inhibitors.
Pavletich NP
J Mol Biol; 1999 Apr; 287(5):821-8. PubMed ID: 10222191
[TBL] [Abstract][Full Text] [Related]
9. Structural insights into the functional diversity of the CDK-cyclin family.
Wood DJ; Endicott JA
Open Biol; 2018 Sep; 8(9):. PubMed ID: 30185601
[TBL] [Abstract][Full Text] [Related]
10. Recent developments in cyclin-dependent kinase biochemical and structural studies.
Echalier A; Endicott JA; Noble ME
Biochim Biophys Acta; 2010 Mar; 1804(3):511-9. PubMed ID: 19822225
[TBL] [Abstract][Full Text] [Related]
11. Visualizing the metazoan proliferation-quiescence decision in vivo.
Adikes RC; Kohrman AQ; Martinez MAQ; Palmisano NJ; Smith JJ; Medwig-Kinney TN; Min M; Sallee MD; Ahmed OB; Kim N; Liu S; Morabito RD; Weeks N; Zhao Q; Zhang W; Feldman JL; Barkoulas M; Pani AM; Spencer SL; Martin BL; Matus DQ
Elife; 2020 Dec; 9():. PubMed ID: 33350383
[TBL] [Abstract][Full Text] [Related]
12. Cyclin-binding motifs are essential for the function of p21CIP1.
Chen J; Saha P; Kornbluth S; Dynlacht BD; Dutta A
Mol Cell Biol; 1996 Sep; 16(9):4673-82. PubMed ID: 8756624
[TBL] [Abstract][Full Text] [Related]
13. Fluorescent Peptide Biosensor for Probing CDK6 Kinase Activity in Lung Cancer Cell Extracts.
Soamalala J; Diot S; Pellerano M; Blanquart C; Galibert M; Jullian M; Puget K; Morris MC
Chembiochem; 2021 Mar; 22(6):1065-1071. PubMed ID: 33112024
[TBL] [Abstract][Full Text] [Related]
14. Iterative conversion of cyclin binding groove peptides into druglike CDK inhibitors with antitumor activity.
Premnath PN; Craig SN; Liu S; Anderson EL; Grigoroudis AI; Kontopidis G; Perkins TL; Wyatt MD; Pittman DL; McInnes C
J Med Chem; 2015 Jan; 58(1):433-42. PubMed ID: 25454794
[TBL] [Abstract][Full Text] [Related]
15. Differential phosphorylation of T-47D human breast cancer cell substrates by D1-, D3-, E-, and A-type cyclin-CDK complexes.
Sarcevic B; Lilischkis R; Sutherland RL
J Biol Chem; 1997 Dec; 272(52):33327-37. PubMed ID: 9407125
[TBL] [Abstract][Full Text] [Related]
16. ATP-noncompetitive inhibitors of CDK-cyclin complexes.
Orzáez M; Gortat A; Mondragón L; Bachs O; Pérez-Payá E
ChemMedChem; 2009 Jan; 4(1):19-24. PubMed ID: 19039815
[TBL] [Abstract][Full Text] [Related]
17. On the concentrations of cyclins and cyclin-dependent kinases in extracts of cultured human cells.
Arooz T; Yam CH; Siu WY; Lau A; Li KK; Poon RY
Biochemistry; 2000 Aug; 39(31):9494-501. PubMed ID: 10924145
[TBL] [Abstract][Full Text] [Related]
18. Characterization of p21Cip1/Waf1 peptide domains required for cyclin E/Cdk2 and PCNA interaction.
Chen IT; Akamatsu M; Smith ML; Lung FD; Duba D; Roller PP; Fornace AJ; O'Connor PM
Oncogene; 1996 Feb; 12(3):595-607. PubMed ID: 8637717
[TBL] [Abstract][Full Text] [Related]
19. Less-well known functions of cyclin/CDK complexes.
Palmer N; Kaldis P
Semin Cell Dev Biol; 2020 Nov; 107():54-62. PubMed ID: 32386818
[TBL] [Abstract][Full Text] [Related]
20. Mechanistic insights into avian reovirus p17-modulated suppression of cell cycle CDK-cyclin complexes and enhancement of p53 and cyclin H interaction.
Chiu HC; Huang WR; Liao TL; Chi PI; Nielsen BL; Liu JH; Liu HJ
J Biol Chem; 2018 Aug; 293(32):12542-12562. PubMed ID: 29907572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
